BioCentury
ARTICLE | Clinical News

AKP-020: Preliminary Phase IIa data

March 24, 2008 7:00 AM UTC

Preliminary data from a single-blind Phase IIa trial in the first four patients showed that treatment with AKP-020 reduced plasma glucose levels in the fasted state and two hours after an OGTT vs. pla...